Variant report
Variant | nsv592436 |
---|---|
Chromosome Location | chr3:163836487-163895047 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:101)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 1)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr3:163881866-163881882 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr3:163890801-163890962 | H1-hESC | embryonic stem cell: | n/a | chr3:163890911-163890922 |
3 | CEBPB | chr3:163890818-163891012 | HepG2 | liver: | n/a | chr3:163890911-163890922 |
4 | CEBPB | chr3:163860167-163860485 | HepG2 | liver: | n/a | chr3:163860323-163860334 |
5 | CEBPB | chr3:163859641-163859926 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr3:163885974-163886233 | A549 | lung: | n/a | chr3:163886110-163886119 chr3:163886110-163886119 chr3:163886110-163886119 chr3:163886109-163886120 chr3:163886108-163886121 chr3:163886108-163886119 chr3:163886110-163886119 |
7 | CEBPB | chr3:163855035-163855235 | HepG2 | liver: | n/a | chr3:163855103-163855114 |
8 | CEBPB | chr3:163886053-163886253 | HepG2 | liver: | n/a | chr3:163886110-163886119 chr3:163886110-163886119 chr3:163886110-163886119 chr3:163886109-163886120 chr3:163886108-163886121 chr3:163886108-163886119 chr3:163886110-163886119 |
9 | CTCF | chr3:163851580-163851730 | HCT-116 | colon: | n/a | n/a |
10 | CTCF | chr3:163843400-163843550 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr3:163851600-163851750 | Hela-S3 | cervix: | n/a | n/a |
12 | CTCF | chr3:163888360-163888510 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr3:163859657-163859699 | Kidney_OC | kidney: | n/a | n/a |
14 | CTCF | chr3:163878567-163878614 | LNCaP | prostate: | n/a | n/a |
15 | CTCF | chr3:163880560-163880710 | Caco-2 | colon: | n/a | n/a |
16 | CTCF | chr3:163888600-163888750 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr3:163851760-163851910 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr3:163881140-163881290 | MCF-7 | breast: | n/a | n/a |
19 | CTCF | chr3:163866020-163866170 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr3:163851640-163851790 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr3:163880560-163880710 | MCF-7 | breast: | n/a | n/a |
22 | CTCF | chr3:163880586-163880705 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr3:163880629-163880686 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr3:163880640-163880685 | MCF-7 | breast: | n/a | n/a |
25 | E2F4 | chr3:163847123-163847160 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | E2F4 | chr3:163848965-163849077 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | E2F4 | chr3:163847853-163848085 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | EP300 | chr3:163872321-163872382 | GM12878 | blood: | n/a | n/a |
29 | FOS | chr3:163873221-163873525 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | FOS | chr3:163841578-163841636 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | FOS | chr3:163873223-163873500 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr3:163873204-163873530 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOXA1 | chr3:163839565-163839900 | T-47D | breast: | n/a | n/a |
34 | FOXA1 | chr3:163880906-163881071 | T-47D | breast: | n/a | n/a |
35 | GATA3 | chr3:163836376-163836487 | SH-SY5Y | brain: | n/a | n/a |
36 | GATA3 | chr3:163862604-163862768 | SH-SY5Y | brain: | n/a | n/a |
37 | JUN | chr3:163872678-163872736 | K562 | blood: | n/a | n/a |
38 | KAP1 | chr3:163865254-163865460 | K562 | blood: | n/a | n/a |
39 | KAP1 | chr3:163862471-163863165 | HEK293 | kidney: | n/a | n/a |
40 | KAP1 | chr3:163867304-163867709 | HEK293 | kidney: | n/a | n/a |
41 | KAP1 | chr3:163862664-163862969 | U2OS | brain: | n/a | n/a |
42 | MAFF | chr3:163838918-163839002 | K562 | blood: | n/a | chr3:163838939-163838957 |
43 | MAFF | chr3:163838836-163838997 | HepG2 | liver: | n/a | chr3:163838939-163838957 |
44 | MAFK | chr3:163848960-163849231 | HepG2 | liver: | n/a | n/a |
45 | MAFK | chr3:163849025-163849180 | HepG2 | liver: | n/a | n/a |
46 | MAFK | chr3:163847161-163847397 | HepG2 | liver: | n/a | chr3:163847247-163847263 chr3:163847274-163847294 chr3:163847251-163847262 chr3:163847276-163847292 chr3:163847250-163847264 |
47 | MAFK | chr3:163838787-163839034 | HepG2 | liver: | n/a | chr3:163838940-163838955 |
48 | MAFK | chr3:163838846-163839006 | HepG2 | liver: | n/a | chr3:163838940-163838955 |
49 | MAX | chr3:163873215-163873582 | NB4 | blood: | n/a | n/a |
50 | MYC | chr3:163873219-163873529 | NB4 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163831824..163833454-chr3:163836559..163838959,2 | K562 | blood: |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-1263 | chr3:163889311-163889332 | MIMAT0005915 |
No data |
Variant related genes | Relation type |
---|---|
MIR1263 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1375832 | chr3:163836487-163836488 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs188028848 | chr3:163836529-163836530 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530169550 | chr3:163836571-163836572 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1375833 | chr3:163836581-163836582 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs540537466 | chr3:163836588-163836589 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368365993 | chr3:163836601-163836602 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13315940 | chr3:163836633-163836634 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs552437297 | chr3:163836717-163836718 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1375834 | chr3:163836735-163836736 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs192849811 | chr3:163836747-163836748 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545832302 | chr3:163836769-163836770 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62280770 | chr3:163836777-163836778 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs373578169 | chr3:163836795-163836796 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531550260 | chr3:163836804-163836805 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1375835 | chr3:163836812-163836813 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs62280771 | chr3:163836863-163836864 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs556822747 | chr3:163836912-163836913 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12497350 | chr3:163836917-163836918 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs189168830 | chr3:163836920-163836921 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560678870 | chr3:163837015-163837016 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545151537 | chr3:163837052-163837053 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530015467 | chr3:163837066-163837067 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573142461 | chr3:163837082-163837083 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541768835 | chr3:163837119-163837120 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561290347 | chr3:163837209-163837210 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530086026 | chr3:163837324-163837325 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543889483 | chr3:163837348-163837349 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181542910 | chr3:163837411-163837412 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13097189 | chr3:163837419-163837420 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs185065143 | chr3:163837442-163837443 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566021807 | chr3:163837559-163837560 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552323133 | chr3:163837607-163837608 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189450315 | chr3:163837610-163837611 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12631347 | chr3:163837622-163837623 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs566735964 | chr3:163837648-163837649 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548601832 | chr3:163837727-163837728 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568042016 | chr3:163837733-163837734 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536684817 | chr3:163837752-163837753 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs180886669 | chr3:163837759-163837760 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570536456 | chr3:163837781-163837782 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538490752 | chr3:163837893-163837894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552391036 | chr3:163837908-163837909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551656970 | chr3:163837931-163837932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569690988 | chr3:163837991-163837992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185922234 | chr3:163838002-163838003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9290226 | chr3:163838015-163838016 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs370076287 | chr3:163838022-163838023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538301866 | chr3:163838031-163838032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543479887 | chr3:163838087-163838088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563362554 | chr3:163838090-163838091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163833000-163837800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:163837800-163839200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:163839200-163852000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:163841400-163841800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr3:163841400-163841800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr3:163841400-163841800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:163841800-163842200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr3:163848600-163849800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr3:163852000-163854600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:163854600-163862000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:163860000-163861400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr3:163862000-163870200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:163863200-163866400 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
14 | chr3:163865800-163867600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
15 | chr3:163868200-163870200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
16 | chr3:163870200-163874600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr3:163873400-163873800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
18 | chr3:163874600-163879600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr3:163875800-163876200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
20 | chr3:163879600-163898800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr3:163881400-163881600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr3:163883600-163885200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr3:163885200-163886000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
24 | chr3:163886000-163886200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
25 | chr3:163890800-163892800 | Enhancers | Dnd41 | blood |
26 | chr3:163892600-163892800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |